TAUNS Laboratories,Inc. (TYO:197A)

Japan · Delayed Price · Currency is JPY

497.00

+1.00 (0.20%)

Apr 1, 2026, 12:54 PM JST

-3.87% (1Y)

Market Cap	52.78B -0.5%
Revenue (ttm)	14.92B -19.0%
Net Income	3.69B -36.1%
EPS	34.36 -36.4%
Shares Out	106.42M
PE Ratio	14.44
Forward PE	9.52
Dividend	28.00 (5.44%)
Ex-Dividend Date	Jun 29, 2026

Volume	661,600
Average Volume	391,580
Open	503.00
Previous Close	496.00
Day's Range	492.00 - 505.00
52-Week Range	418.00 - 618.00
Beta	n/a
RSI	34.96
Earnings Date	May 14, 2026

About TAUNS Laboratories,Inc.

TAUNS Laboratories,Inc. engages in the development, manufacture, export/import, and sale of in vitro diagnostics and research reagents, and its intermediates in Japan and internationally. The company also offers medical physicochemical measuring equipment, industrial measuring equipment, and medical devices; and contract research services. The company was founded in 1987 and is headquartered in Izunokuni, Japan. [Read more]

Industry Medical - Specialties

Sector Healthcare

Founded 1987

Employees 218

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 197A

Full Company Profile

Financial Performance

In fiscal year 2025, TAUNS Laboratories,Inc.'s revenue was 18.63 billion, an increase of 1.05% compared to the previous year's 18.43 billion. Earnings were 6.32 billion, an increase of 9.38%.

Financial Statements